Tech Company Financing Transactions
Human Longevity Funding Round
On 4/5/2016, Human Longevity raised $220 million in Series B financing from Celgene, GE Ventures and Illumina Ventures.
Transaction Overview
Company Name
Announced On
4/5/2016
Transaction Type
Venture Equity
Amount
$220,000,000
Round
Series B
Investors
Proceeds Purpose
HLI is using the proceeds from this round to fund the growth and expansion of the company and our growing line of products. These include the first Health Nucleus, HLI's comprehensive, genomic-enhanced, research-based health center; ongoing development of the HLI Knowledgebase which currently has more than 20,000 complete genomes coupled with phenotype data; the Comprehensive Cancer Program and other sequencing programs.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4570 Executive Dr.
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
Human Longevity, Inc. (HLI) is the genomics-based, technology-driven company creating the world's largest and most comprehensive database of whole genome, phenotype and clinical data.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 4/5/2016: Veestro venture capital transaction
Next: 4/5/2016: Mintigo venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs